Using exome sequencing to reveal mutations in TREM2 presenting as a frontotemporal dementia-like syndrome without bone involvement
- PMID: 23318515
- PMCID: PMC4001789
- DOI: 10.1001/jamaneurol.2013.579
Using exome sequencing to reveal mutations in TREM2 presenting as a frontotemporal dementia-like syndrome without bone involvement
Abstract
Objective: To identify new genes and risk factors associated with frontotemporal dementia (FTD). Several genes and loci have been associated with different forms of FTD, but a large number of families with dementia do not harbor mutations in these genes.
Design: Whole-exome sequencing and whole-genome genotyping were performed in all patients. Genetic variants obtained from whole-exome sequencing were integrated with the data obtained from whole-genome genotyping.
Setting: Database of the Behavioral Neurology Outpatient Clinic of the Department of Neurology, Istanbul Faculty of Medicine, Istanbul, Turkey. PATIENTS Forty-four Turkish patients with an FTD-like clinical diagnosis were included in the study. Relatives were screened when appropriate.
Main outcome measure: Mutations in the triggering receptor expressed on myeloid cells 2 gene (TREM2).
Results: In 3 probands with FTD-like disease, we identified different homozygous mutations in TREM2 that had previously been associated with polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy (PLOSL). None of these 3 patients had a typical clinical presentation of PLOSL: they presented with behavioral change and subsequent cognitive impairment and motor features but without any bone cysts or bone-associated phenotypes. Imaging showed white matter abnormalities as well as frontal atrophy in all 3 patients.
Conclusions: Our results show that TREM2 is responsible for an unexpectedly high number of dementia cases in our cohort, suggesting that this gene should be taken into account when mutations in other dementia genes are excluded. Even for complex syndromes such as dementia, exome sequencing has proven to be a rapid and cost-effective tool to identify genetic mutations, allowing for the association of clinical phenotypes with unexpected molecular underpinnings.
Figures





Comment in
-
TREM2, frontotemporal dementia-like disease, Nasu-Hakola disease, and Alzheimer dementia: a chicken and egg problem?JAMA Neurol. 2013 Jun;70(6):805-6. doi: 10.1001/jamaneurol.2013.453. JAMA Neurol. 2013. PMID: 23753970 No abstract available.
Similar articles
-
Targeted exome sequencing reveals homozygous TREM2 R47C mutation presenting with behavioral variant frontotemporal dementia without bone involvement.Neurobiol Aging. 2018 Aug;68:160.e15-160.e19. doi: 10.1016/j.neurobiolaging.2018.04.003. Epub 2018 Apr 16. Neurobiol Aging. 2018. PMID: 29748150
-
TREM2 mutations are rare in a French cohort of patients with frontotemporal dementia.Neurobiol Aging. 2013 Oct;34(10):2443.e1-2. doi: 10.1016/j.neurobiolaging.2013.04.030. Epub 2013 Jun 4. Neurobiol Aging. 2013. PMID: 23759145
-
Novel compound heterozygous mutation in TREM2 found in a Turkish frontotemporal dementia-like family.Neurobiol Aging. 2013 Dec;34(12):2890.e1-5. doi: 10.1016/j.neurobiolaging.2013.06.005. Epub 2013 Jul 17. Neurobiol Aging. 2013. PMID: 23870839 Free PMC article. Review.
-
Mutations in TYROBP are not a common cause of dementia in a Turkish cohort.Neurobiol Aging. 2017 Oct;58:240.e1-240.e3. doi: 10.1016/j.neurobiolaging.2017.06.019. Epub 2017 Jun 28. Neurobiol Aging. 2017. PMID: 28716534 Free PMC article.
-
Nasu-Hakola disease (polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy--PLOSL): a dementia associated with bone cystic lesions. From clinical to genetic and molecular aspects.Cell Mol Neurobiol. 2004 Feb;24(1):1-24. doi: 10.1023/b:cemn.0000012721.08168.ee. Cell Mol Neurobiol. 2004. PMID: 15049507 Free PMC article. Review.
Cited by
-
Integration of bioinformatics and imaging informatics for identifying rare PSEN1 variants in Alzheimer's disease.BMC Med Genomics. 2016 Aug 12;9 Suppl 1(Suppl 1):30. doi: 10.1186/s12920-016-0190-9. BMC Med Genomics. 2016. PMID: 27535542 Free PMC article.
-
Genes associated with Alzheimer's disease: an overview and current status.Clin Interv Aging. 2016 May 17;11:665-81. doi: 10.2147/CIA.S105769. eCollection 2016. Clin Interv Aging. 2016. PMID: 27274215 Free PMC article. Review.
-
Therapeutic Trem2 activation ameliorates amyloid-beta deposition and improves cognition in the 5XFAD model of amyloid deposition.J Neuroinflammation. 2020 Aug 14;17(1):238. doi: 10.1186/s12974-020-01915-0. J Neuroinflammation. 2020. PMID: 32795308 Free PMC article.
-
Rodent Models of Amyloid-Beta Feature of Alzheimer's Disease: Development and Potential Treatment Implications.Aging Dis. 2020 Oct 1;11(5):1235-1259. doi: 10.14336/AD.2019.1026. eCollection 2020 Oct. Aging Dis. 2020. PMID: 33014535 Free PMC article. Review.
-
TREM2 is associated with the risk of Alzheimer's disease in Spanish population.Neurobiol Aging. 2013 Jun;34(6):1711.e15-7. doi: 10.1016/j.neurobiolaging.2012.12.018. Epub 2013 Feb 5. Neurobiol Aging. 2013. PMID: 23391427 Free PMC article.
References
-
- Baker M, Mackenzie IR, Pickering-Brown SM, et al. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature. 2006;442(7105):916–919. - PubMed
-
- Cruts M, Gijselinck I, van der Zee J, et al. Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature. 2006;442(7105):920–924. - PubMed
-
- Hutton M, Lendon CL, Rizzu P, et al. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature. 1998;393(6686):702–705. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources